Satellos Bioscience Stock Today
| MSCL Stock | 0.83 0.04 5.06% |
PerformanceWeak
| Odds Of DistressLow
|
Satellos Bioscience is selling at 0.83 as of the 8th of January 2026; that is 5.06% up since the beginning of the trading day. The stock's open price was 0.79. Satellos Bioscience has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 9th of December 2025 and ending today, the 8th of January 2026. Click here to learn more.
Category Healthcare |
Satellos Bioscience is entity of Canada. It is traded as Stock on TO exchange. The company has 185.51 M outstanding shares of which 245.57 K shares are now shorted by private and institutional investors with about 1.33 days to cover all short positions. More on Satellos Bioscience
Moving together with Satellos Stock
Moving against Satellos Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Satellos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Satellos Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Satellos Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, CoFounder | Francis MBA |
| Business Concentration | Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) |
Satellos Bioscience (MSCL) is traded on Toronto Exchange in Canada and employs 14 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 146.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Satellos Bioscience's market, we take the total number of its shares issued and multiply it by Satellos Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Satellos Bioscience operates under Healthcare sector and is part of Biotechnology industry. The entity has 185.51 M outstanding shares of which 245.57 K shares are now shorted by private and institutional investors with about 1.33 days to cover all short positions.
Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations.
Check Satellos Bioscience Probability Of Bankruptcy
Ownership AllocationSatellos Bioscience shows a total of 185.51 Million outstanding shares. Satellos Bioscience has 8.3 % of its outstanding shares held by insiders and 8.2 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Satellos Ownership Details
Satellos Bioscience Historical Income Statement
Satellos Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Satellos Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Satellos Bioscience Corporate Management
Elected by the shareholders, the Satellos Bioscience's board of directors comprises two types of representatives: Satellos Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Satellos. The board's role is to monitor Satellos Bioscience's management team and ensure that shareholders' interests are well served. Satellos Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Satellos Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA | Chief Officer | Profile | |
| Philip MA | Chief Officer | Profile | |
| CPA CMA | Head Strategy | Profile | |
| Ryan Mitchell | Vice Development | Profile | |
| Desiree Chan | Chief Staff | Profile |
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.